Spirea

Spirea

Biotechnology Research

Unlocking the next generation of antibody drug conjugates

About us

Spirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. Spirea will use its innovative technology to enable a pipeline of superior and differentiated antibody drug conjugates for the treatment of a range of solid tumours.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Cambridge
Type
Privately Held

Locations

Employees at Spirea

Updates

Similar pages

Browse jobs

Funding